Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cell Therapy for Patients With Symptomatic Knee Osteoarthritis: Phase I / II, Controlled, Randomized and Double-blind Clinical Trial

NCT04863183 is registered in ClinicalTrials.gov with Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle as lead sponsor.

NCT NCT04863183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cell Therapy for Patients With Symptomatic Knee Osteoarthritis: Phase I / II, Controlled, Randomized and Double-blind Clinical Trial
Lead sponsor
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 1, 2021
Completion date
June 30, 2022
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cell therapy, knee osteoarthritis, mesenchymal stem cells